NasdaqCM - Delayed Quote USD

Longeveron Inc. (LGVN)

1.7200 -0.1000 (-5.49%)
At close: April 24 at 4:00 PM EDT
1.7100 -0.01 (-0.58%)
After hours: April 24 at 7:59 PM EDT
Loading Chart for LGVN
DELL
  • Previous Close 1.8200
  • Open 1.8200
  • Bid 1.7100 x 300
  • Ask 1.7400 x 400
  • Day's Range 1.6800 - 1.8300
  • 52 Week Range 1.6200 - 44.0000
  • Volume 303,001
  • Avg. Volume 2,103,304
  • Market Cap (intraday) 8.721M
  • Beta (5Y Monthly) 0.20
  • PE Ratio (TTM) --
  • EPS (TTM) -9.6500
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 30.05

Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States and Japan. The company's lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors. It is conducting Phase 1, Phase 1/2, Phase 2a, and Phase 2b clinical trials in various indications, such as aging-related frailty, alzheimer's disease, and hypoplastic left heart syndrome. The company was incorporated in 2014 and is headquartered in Miami, Florida.

longeveron.com

23

Full Time Employees

December 31

Fiscal Year Ends

Recent News: LGVN

Performance Overview: LGVN

Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

LGVN
87.35%
S&P 500
6.33%

1-Year Return

LGVN
93.99%
S&P 500
22.70%

3-Year Return

LGVN
97.08%
S&P 500
21.33%

5-Year Return

LGVN
--
S&P 500
28.89%

Compare To: LGVN

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: LGVN

Valuation Measures

Annual
As of 4/24/2024
  • Market Cap

    8.25M

  • Enterprise Value

    4.93M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    5.27

  • Price/Book (mrq)

    1.22

  • Enterprise Value/Revenue

    6.96

  • Enterprise Value/EBITDA

    -0.25

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -66.49%

  • Return on Equity (ttm)

    -157.19%

  • Revenue (ttm)

    709k

  • Net Income Avi to Common (ttm)

    -22.21M

  • Diluted EPS (ttm)

    -9.6500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    5.36M

  • Total Debt/Equity (mrq)

    30.28%

  • Levered Free Cash Flow (ttm)

    -11.72M

Research Analysis: LGVN

Analyst Price Targets

15.00
30.05 Average
1.7200 Current
60.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: LGVN

Fair Value

1.7200 Current
 

Dividend Score

0 Low
LGVN
Sector Avg.
100 High
 

Hiring Score

0 Low
LGVN
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
LGVN
Sector Avg.
100 High
 

Research Reports: LGVN

  • Daily – Vickers Top Buyers & Sellers for 01/12/2024

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

     
  • Daily – Vickers Top Buyers & Sellers for 01/02/2024

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

     
  • Daily – Vickers Top Insider Picks for 01/07/2022

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

     
  • Daily – Vickers Top Insider Picks for 01/06/2022

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

     

People Also Watch